RJFSA
IONS icon

Raymond James Financial Services Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$584K Sell
14,570
-765
-5% -$35.6K ﹤0.01% 2512
2024
Q2 		$731K Buy
15,335
+1,827
+14% +$74.9K ﹤0.01% 2279
2024
Q1 		$586K Sell
13,508
-139
-1% -$6.63K ﹤0.01% 2399
2023
Q4 		$690K Buy
13,647
+1,390
+11% +$66.6K ﹤0.01% 2208
2023
Q3 		$556K Sell
12,257
-1,885
-13% -$77.8K ﹤0.01% 2260
2023
Q2 		$580K Sell
14,142
-11,510
-45% -$442K ﹤0.01% 2260
2023
Q1 		$917K Sell
25,652
-1,073
-4% -$40.3K ﹤0.01% 1957
2022
Q4 		$1.01M Sell
26,725
-5,839
-18% -$246K ﹤0.01% 1832
2022
Q3 		$1.44M Sell
32,564
-21,666
-40% -$913K ﹤0.01% 1612
2022
Q2 		$2.01M Buy
54,230
+3,645
+7% +$137K ﹤0.01% 1437
2022
Q1 		$1.87M Buy
50,585
+1,604
+3% +$52.5K ﹤0.01% 1540
2021
Q4 		$1.49M Buy
48,981
+2,825
+6% +$88.9K ﹤0.01% 1722
2021
Q3 		$1.55M Buy
46,156
+1,325
+3% +$49.9K ﹤0.01% 1647
2021
Q2 		$1.79M Buy
44,831
+9,302
+26% +$364K ﹤0.01% 1538
2021
Q1 		$1.6M Buy
35,529
+17,167
+93% +$957K ﹤0.01% 1533
2020
Q4 		$1.04M Buy
18,362
+3,671
+25% +$183K ﹤0.01% 1673
2020
Q3 		$697K Sell
14,691
-1,839
-11% -$102K ﹤0.01% 1773
2020
Q2 		$975K Buy
16,530
+441
+3% +$24.5K ﹤0.01% 1502
2020
Q1 		$761K Buy
16,089
+2,754
+21% +$154K ﹤0.01% 1338
2019
Q4 		$806K Sell
13,335
-3,657
-22% -$218K ﹤0.01% 1671
2019
Q3 		$1.02M Sell
16,992
-3,088
-15% -$201K ﹤0.01% 1470
2019
Q2 		$1.29M Buy
20,080
+2,923
+17% +$207K 0.01% 1352
2019
Q1 		$1.39M Buy
17,157
+7,433
+76% +$479K 0.01% 1267
2018
Q4 		$526K Sell
9,724
-871
-8% -$44.4K ﹤0.01% 1638
2018
Q3 		$546K Buy
10,595
+122
+1% +$5.73K ﹤0.01% 1843
2018
Q2 		$436K Sell
10,473
-8,176
-44% -$362K ﹤0.01% 1967
2018
Q1 		$822K Buy
18,649
+1,131
+6% +$57.5K ﹤0.01% 1430
2017
Q4 		$881K Sell
17,518
-3,047
-15% -$167K 0.01% 1375
2017
Q3 		$1.04M Sell
20,565
-910
-4% -$47.7K 0.01% 1279
2017
Q2 		$1.09M Buy
21,475
+1,421
+7% +$66.2K 0.01% 1211
2017
Q1 		$806K Sell
20,054
-357
-2% -$16K 0.01% 1302
2016
Q4 		$976K Sell
20,411
-8,999
-31% -$356K 0.01% 1129
2016
Q3 		$1.08M Buy
29,410
+610
+2% +$19.1K 0.01% 1048
2016
Q2 		$671K Buy
28,800
+3,671
+15% +$118K 0.01% 1260
2016
Q1 		$1.02M Buy
25,129
+1,308
+5% +$53.1K 0.01% 900
2015
Q4 		$1.48M Sell
23,821
-5,188
-18% -$280K 0.02% 764
2015
Q3 		$1.17M Buy
+29,009
New +$1.5M 0.02% 718

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Raymond James Financial Services Advisors's IONS Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 5% in Q3 2024, selling an estimated $35.6K and leaving 14,570 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Raymond James Financial Services Advisors first reported a position in IONS in Q3 2015 and has held it in 37 quarters since. The position peaked at $2.01M in Q2 2022. 354 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • Raymond James Financial Services Advisors held 14,570 shares of Ionis Pharmaceuticals worth $584K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 765 Ionis Pharmaceuticals shares in Q3 2024, an estimated $35.6K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2512 holding.
  • Raymond James Financial Services Advisors first reported a position in Ionis Pharmaceuticals in Q3 2015 and has held it in 37 quarters since.
  • Raymond James Financial Services Advisors's Ionis Pharmaceuticals position peaked at $2.01M in Q2 2022.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.